Cell Biologics is a premier manufacturer of primary cultured cells and cell culture products. We provide a broad range of high-quality human and animal primary cells including endothelial, epithelial, tumor and stem cells, along with optimized cell culture media and other related products. Mouse primary endothelial cells were first offered from Cell Biologics and can be custom ordered for specific scientific needs. You can count on our high quality custom cell isolation service! The company is also developing therapeutic platforms targeting inflammatory diseases and novel delivery systems for therapeutically active biologics.

Founded in September 2000, Shanghai Model Organisms Center, Inc. (SMOC) specializes in model organisms and is dedicated to gene editing and life decoding.

We provide customized solutions such as genetically engineered animal models, phenotype analysis, and high-throughput screenings to advance life science research and drug discovery. SMOC owns a rapidly growing repository of Research-Ready models, including immunodeficient and humanized mouse models to advance R&D for cancer immunotherapy.

Health and safety procedures for animal handling are strictly complied with. Animal welfare is highly prioritized by SMOC and which has earned us the AAALAC accreditation.

• Our mission is to edit genes and decode life.
• Our vision is to become the leader in the field of genetically modified animal models, helping people understand life science and improving the quality of life around the world.
• Our values are Innovation, Dedication, Friendship, and Responsibility.

MountView Therapeutics is a biopharmaceutical company developing next generation transformative technologies for gene and drug delivery targeting vascular endothelium to treat human diseases.

Transformative endothelium-targeted regulatable gene therapy: Precise and Effective

The proprietary nanoparticle delivery platform is the next generation small molecule and gene delivery technology targeting the vascular endothelium without gene size limitation. It can deliver CRISPR/Cas9 and other genome editors, and any transgene(s) in a regulatable, organ and cell-specific manner, and modulate the expression of multiple genes simultaneously for treatment of various diseases caused by endothelial dysfunction including cardiovascular diseases, hypertension, pulmonary arterial hypertension, severe sepsis, acute respiratory distress syndrome, cancer, and cancer metastasis. 

Precision gene therapy makes one’s endothelium forever young and rejuvenates aged endothelium for healthy life

The biotech team also provides nanoparticle products for rapid robust gene expression modulation (knockout and/or overexpresison of 1-5 genes simultaneously) selectively in vascular endothelial cells in mice and rats at any ages. It can modulate gene expression in a regulatable, organ and cell-specific manner.  

Make single or double knockout mice as quick as a week instead of 1-2 years

RWD originated from the transliteration of the word “Reward,” meaning “payback to society. “Reward” is not only the initial intention of the creation of RWD but also the continuous goal of us.

We are a world’s leading manufacturer of life science research instruments, and medical devices, specializing in the fields of respiratory anesthesia, neuroscience research, animal behavior research, surgery and nursing, and pathological analysis, animal health. Since 2002, headquartered in China, branch in USA, we have rolled out products and services for over 100 countries and regions, already serviced 6,000+ universities, 1,000+research institutes, 300+hospitals, 11,000+veterinary clinics, gaining constant trust and support from global customers after our efforts.

The product range includes lab animal research equipment including (anesthesia machine, stereotaxic, etc), cell& molecular biology, histopathological diagnosis, and veterinary medical equipment.

Looking into the future, we shall adhere to the core values of quality, integrity, responsibility and contribute to the advancement and development of pre-clinic and medical clinic applications.